Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
A tumor antigen is an antigenic substance produced by tumor cells that can trigger an immune response in the host. These antigens are either unique to cancer cells or are present at much higher levels in tumors compared to normal tissues, making them useful as both diagnostic markers and therapeutic targets. They are broadly classified into tumor-specific antigens (TSAs) and tumor-associated antigens (TAAs). TSAs are unique to tumor cells and often arise from mutations, while TAAs are present at elevated levels on tumor cells but may also be expressed at lower levels on some normal tissues.
Targeting tumor cells for destruction via antibody-mediated cytotoxicity, immune cell activation, or drug delivery.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Tumor Antigen.